Page last updated: 2024-10-31

n(1),n(11)-diethylnorspermine and Benign Neoplasms, Brain

n(1),n(11)-diethylnorspermine has been researched along with Benign Neoplasms, Brain in 2 studies

N(1),N(11)-diethylnorspermine: structure given in first source

Research Excerpts

ExcerptRelevanceReference
"This 52-year-old male without a significant medical history was receiving chemotherapy with diethylnorspermine (DENSPM), a polyamine analogue, for a partially resected pancreatic adenocarcinoma."3.70Chemotherapy for pancreatic cancer: a neuroimaging clinicopathologic correlation. ( Rojiani, AM; Valenstein, EJ; Williams, LS, 1999)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Tian, Y1
Wang, S1
Wang, B1
Zhang, J1
Jiang, R1
Zhang, W1
Rojiani, AM1
Williams, LS1
Valenstein, EJ1

Other Studies

2 other studies available for n(1),n(11)-diethylnorspermine and Benign Neoplasms, Brain

ArticleYear
Overexpression of SSAT by DENSPM treatment induces cell detachment and apoptosis in glioblastoma.
    Oncology reports, 2012, Volume: 27, Issue:4

    Topics: Acetyltransferases; Antineoplastic Agents; Apoptosis; Brain Neoplasms; Cell Adhesion; Cell Line, Tum

2012
Chemotherapy for pancreatic cancer: a neuroimaging clinicopathologic correlation.
    Journal of neuroimaging : official journal of the American Society of Neuroimaging, 1999, Volume: 9, Issue:3

    Topics: Adenocarcinoma; Antineoplastic Agents; Brain; Brain Neoplasms; Demyelinating Diseases; Diagnosis, Di

1999